Gary B. Gordon SEC EDGAR Filings (CIK 0001811354)

SEC EDGAR filings, ownership reports, and insider transactions for Gary B. Gordon.

Business address
C/O Ayala Pharmaceuticals, Inc., Oppenheimer 4, Rehovot, Israel, 7670104
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Gary B. Gordon has filed 10 SEC EDGAR filings since 07 May 2020

Latest Filings

Recent SEC filings for Gary B. Gordon including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 27 Jun 2025 12 Jun 2025 001-39813
4 Open 4 document View SEC filing for 4 31 Jan 2025 29 Jan 2025 001-39813
3 Open 3 document View SEC filing for 3 31 Jan 2025 29 Jan 2025 001-39813
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 23 Jan 2023 19 Jan 2023 001-39279
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 16 May 2022 16 May 2022 001-39279
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Jan 2022 03 Jan 2022 001-39279
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Feb 2021 24 Feb 2021 001-39279
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Jan 2021 20 Jan 2021 001-39279
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Jan 2021 04 Jan 2021 001-39279
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 07 May 2020 07 May 2020 001-39279

About this filer

Gary B. Gordon files with the SEC under CIK 0001811354. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages